Story · Medicine & Biotech

FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality

1 outlet · first reported by FDA Press Announcements 9d ago

Coverage, in order

  1. 9d ago
    FDA Press Announcements indie
    FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality

    The U.S. Food and Drug Administration today issued final guidance for manufacturers of cellular and gene therapy (CGT) products to implement a comprehensive, science- and risk-based plan for making sure their products meet potency standards.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.